How GLP-1 Drugs Are Transforming Consumer Behavior and What Businesses Should Do About It Contents This research was conducted on 12/17/25 and made possible using Virtual Audiences GLP-1 receptor agonists (medications like Ozempic, Wegovy, Mounjaro, and Zepbound) are no longer just treatments for diabetes or obesity
Research-peptide and compounded forms of afamelanotide are not FDA-approved for any indication.
Milman, S., Huffman, D
Your blood sugar, electrolytes, and medication absorption may shift unpredictably during prolonged fasting periods
The prescription requirement exists because GLP-1 medications carry real risks: nausea, pancreatitis risk markers, gastrointestinal complications, and potential thyroid concerns in susceptible populations
They look around and everybody's like, oh, it must be funny because he's just got confidence by it